As a corporate finance leader with 30 years of public and private experience, my strengths lie in leading financial, operational, strategic and M&A initiatives requiring complex financial expertise. Most recently, I have served public Life Sciences and Technology companies in CFO, Secretary and Treasurer, VP of Finance and Controller positions. In these roles, I've directed public equity offerings of up to $115 million in size and helped organizations make major strides in achieving cash flow profitability, capital formation, IR, financial reporting, corporate compliance and reorganization. I recently co-led an M&A process that resulted in the successful sale of CombiMatrix to Invitae Corp. for 2.7X 2016 revenues. Prior to my corporate leadership tenures, I spent 9 years in the ranks of "Big 5" public accounting firm Arthur Andersen, auditing and providing business consulting services to dozens of firms, including the office’s largest client at the time. Since 2016 I have served on three public company Boards of Directors and am currently a director and Audit Committee Chairman of Microbot Medical (Nasdaq: MBOT).Areas of expertise include:• Capital Raising• Corporate accounting/finance leadership• SEC filing and financial reporting, including SOX and GAAP compliance• Mergers/Acquisition due diligence, planning, structuring, and integration• FP&A department leadership and data-driven decision support• Board membership and support• Human Resources, IT and Legal oversight• Corporate restructuring, change management, and turnaround leadership• IR, Wall Street analysts and banking relationship management• CPA (inactive)My industry background centers around Biotechnology & Life Sciences, High Technology, Telecommunications, Hospitality and Real Estate. I am currently a member of the National Association of Corporate Directors, the Forum for Corporate Directors - Orange County and the American Institute of CPAs.